Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Characterization of concentration- and use-dependent effects of quinidine from conduction delay and declining conduction velocity in canine Purkinje fibers.
D L Packer, … , H C Strauss, C F Starmer
D L Packer, … , H C Strauss, C F Starmer
Published June 1, 1989
Citation Information: J Clin Invest. 1989;83(6):2109-2119. https://doi.org/10.1172/JCI114124.
View: Text | PDF
Research Article

Characterization of concentration- and use-dependent effects of quinidine from conduction delay and declining conduction velocity in canine Purkinje fibers.

  • Text
  • PDF
Abstract

The dynamic response of squared conduction velocity, theta 2, to repetitive stimulation in canine Purkinje fibers with quinidine was studied using a double-microelectrode technique. With stimulation, a frequency-dependent monoexponential increase in conduction delay (CD) and a decline in theta 2 were observed. The exponential rates and changes in steady-state CD and theta 2 were frequency- and concentration-dependent. The overall drug uptake rates describing blockade and the interpulse recovery interval were linearly related and steady-state values of theta 2 were linearly related to an exponential function of the stimulus intervals. Based on first-order binding, the frequency- and concentration-dependent properties of quinidine were characterized by the apparent binding and unbinding rates of 14.2 +/- 5.7 X 10(6) mol-1.s-1 and 63 +/- 12 s-1 for activated and 14.8 +/- 1.0 X 10(2) mol-1.s-1 and 0.16 +/- 0.03 s-1 for resting states. The recovery time constant extracted from the pulse train interpulse interval was 5.8 +/- 1.5 s compared with 5.1 +/- 0.6 s determined from a posttrain test pulse protocol. This study demonstrates that the kinetics of drug action can be derived from measures of impulse propagation. This provides a basis for characterizing frequency-dependent properties of antiarrhythmic agents in vivo and suggests the plausibility of a quantitative assessment of drug binding and recovery rates in man.

Authors

D L Packer, A O Grant, H C Strauss, C F Starmer

×

Total citations by year

Year: 2013 2008 2003 1998 1997 1996 1995 1994 1993 1992 1991 Total
Citations: 1 1 2 1 3 1 1 3 1 3 2 19
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (19)

Title and authors Publication Year
Application of quinidine on rat sciatic nerve decreases the amplitude and increases the latency of evoked responses
KI Cheng, IL Lin, LL Chang, IM Jou, CS Lai, JJ Wang, HC Wang, AL Kwan
Journal of Anesthesia 2013
Termination of equine atrial fibrillation by quinidine: An optical mapping study
FH Fenton, EM Cherry, BG Kornreich
Journal of Veterinary Cardiology 2008
Dual Rate-dependent Cardiac Electrophysiologic Effects of Haloperidol: Slowing of Intraventricular Conduction and Lengthening of Repolarization
D Mörtl, E Agneter, P Krivanek, K Koppatz, H Todt
Journal of Cardiovascular Pharmacology 2003
Voltage-Dependent Profile of Human Ether-a-go-go -Related Gene Channel Block Is Influenced by a Single Residue in the S6 Transmembrane Domain
JA Sănchez-Chapula, T Ferrer, RA Navarro-Polanco, MC Sanguinetti
Molecular pharmacology 2003
Molecular mechanisms of the reversal of imipramine-induced sodium channel blockade by alkalinization in human cardiac myocytes
E Bou-Abboud, S Nattel
Cardiovascular Research 1998
The Cardiac Vulnerable Period and Reentrant Arrhythmias: Targets of Anti- and Proarrhythmic Processes
CF Starmer
Pacing and Clinical Electrophysiology 1997
Mechanism of Lethal Proarrhythmia Observed in the Cardiac Arrhythmia Suppression Trial: Role of Adrenergic Modulation of Drug Binding
DL Packer, TM Munger, SB Johnson, KT Cragun
Pacing and Clinical Electrophysiology 1997
β-Adrenergic Augmentation of Flecainide-Induced Conduction Slowing in Canine Purkinje Fibers
KT Cragun, SB Johnson, DL Packer
Circulation 1997
Differential Effects of Changes in Local Myocardial Refractoriness on Atrialand Ventricular Latency
L Fananapazir, D Packer, EN Prystowsky
Circulation 1996
Basic Concepts in Cellular Cardiac Electrophysiology: Part II: Block of Ion Channels by Antiarrhythmic Drugs
DW Whalley, DJ Wendt, AO Grant
Pacing and Clinical Electrophysiology 1995
Direct quantification of apparent binding indices from quinidine-induced in vivo conduction delay in canine myocardium
FN Haugland, SB Johnson, DL Packer
Journal of Clinical Investigation 1994
Prolongation of the QT interval by dofetilide modulates rate-dependent effects of mexiletine on intraventricular conduction
H Todt, N Zojer, G Raberger, W Schütz
European Journal of Pharmacology 1994
Modulation of procainamide's effect on cardiac conduction in dogs by extracellular potassium concentration. A quantitative analysis
C Villemaire, S Nattel
Circulation 1994
Kinetics of rate-dependent slowing of intraventricular conduction by the class Ib antiarrhythmic agent tocainide in vivo
H Todt, N Zojer, G Raberger
British Journal of Pharmacology 1993
The Frequency-Dependent Effects of Verapamil on Antegrade Refractory Periods and Conduction in the Atrioventricular Node in Man
AB Curtis, K Ellenbogen, JM Harton, HC Trauss
Journal of Cardiovascular Electrophysiology 1992
Use-dependent electrophysiologic effects of amiodarone in coronary artery disease and inducible ventricular tachycardia
N Chiamvimonvat, LB Mitchell, AM Gillis, DG Wyse, RS Sheldon, HJ Duff
The American Journal of Cardiology 1992
A quantitative analysis of use-dependent ventricular conduction slowing by procainamide in anesthetized dogs
C Villemaire, P Savard, M Talajic, S Nattel
Circulation 1992
A prospective comparison of class IA, B, and C antiarrhythmic agents in combination with amiodarone in patients with inducible, sustained ventricular tachycardia
L Toivonen, A Kadish, F Morady
Circulation 1991
Kinetics of use-dependent ventricular conduction slowing by antiarrhythmic drugs in humans
S Ranger, M Talajic, R Lemery, D Roy, C Villemaire, S Nattel
Circulation 1991

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts